Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cataract - nephropathy - encephalopathy syndrome describes a lethal combination of manifestations including short stature, congenital cataracts, encephalopathy with epileptic fits, and postmortem confirmation of nephropathy (renal tubular necrosis). The combination of cataract - nephropathy - encephalopathy has been described in 2 female infant children of first cousin parents. The infants did not survive beyond 4 and 8 months respectively. There have been no further descriptions in the literature since 1963.
Features include always present findings: Microcephaly, Seizure, Renal tubular epithelial necrosis, and Cerebellar dysplasia and others; and common findings: Nystagmus. 9 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 3 | Seizure, Severe global developmental delay, Intellectual disability |
Biomarker and diagnostic research for cataract-nephropathy-encephalopathy syndrome has been reported in the published literature.
Phenotype severity distribution: 7 always present features, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for cataract-nephropathy-encephalopathy syndrome.
222 publications have been identified in PubMed for cataract-nephropathy-encephalopathy syndrome. Research spans Review / Meta-Analysis (55%), Epidemiology / Natural History (15%), and Basic Science / Preclinical (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 121 | 55% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 7:51 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Eyes
2 |
Nystagmus, Developmental cataract |
Head and neck | 1 | Microcephaly |
Growth and development | 1 | Short stature |
Kidneys and urinary system | 1 | Renal tubular epithelial necrosis |
Age of onset: infancy, at birth.
Disease patterns and progression
33 |
15% |
Laboratory research | 28 | 13% |
Patient case studies | 21 | 9% |
Other research | 7 | 3% |
Testing and diagnosis research | 5 | 2% |
Clinical study results | 5 | 2% |
New treatment approaches | 2 | 1% |
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Aguilar AA (2026). [PMID: 41758717](https://pubmed.ncbi.nlm.nih.gov/41758717/). *AACN Adv Crit Care*. [Review / Meta-Analysis]
Asghar E (2026). [PMID: 41401403](https://pubmed.ncbi.nlm.nih.gov/41401403/). *Ocul Immunol Inflamm*. [Review / Meta-Analysis]
Khoo SE (2026). [PMID: 41102056](https://pubmed.ncbi.nlm.nih.gov/41102056/). *Int J Oral Maxillofac Surg*. [Basic Science / Preclinical]
Avelino-Silva TJ (2026). [PMID: 41591773](https://pubmed.ncbi.nlm.nih.gov/41591773/). *JAMA Netw Open*. [Epidemiology / Natural History]
Sebode M (2026). [PMID: 41432137](https://pubmed.ncbi.nlm.nih.gov/41432137/). *Curr Opin Gastroenterol*. [Review / Meta-Analysis]
Vialle R (2026). [PMID: 40976314](https://pubmed.ncbi.nlm.nih.gov/40976314/). *Orthop Traumatol Surg Res*. [Review / Meta-Analysis]
Garcia-Usó M (2026). [PMID: 41004638](https://pubmed.ncbi.nlm.nih.gov/41004638/). *Cleft Palate Craniofac J*. [Epidemiology / Natural History]
Serpieri V (2026). [PMID: 41720098](https://pubmed.ncbi.nlm.nih.gov/41720098/). *Am J Hum Genet*. [Epidemiology / Natural History]